Search - tctmd.com

Displaying 61 - 80 of 9029

Sort: Relevancy | Date

Presentation THT 2026

The Highly Dynamic Nature Of Diuretic Response In Acute Heart Failure: Insights From The FASTR Trial

Presenter: Jeffrey Testani

March 04, 2026

News Daily News

Healthy Lifestyle Plus GLP-1s Yields Bigger CV Reduction Than Drugs Alone

Michael O'Riordan

March 03, 2026

Presentation THT 2026

Evaluating Electronic Health Record-Integrated Artificial Intelligence System In Combining Structured and Unstructured Data to Make Clinical Trial Eligibility Determination

Presenter: Trejeeve Martyn

March 03, 2026

Presentation THT 2026

Comprehensive clinical benefit of CCM in HFrEF patients – a win-ratio analysis of FIX-HF-5C randomized trial

Presenter: Rami Kahwash

March 03, 2026

Presentation THT 2026

Impact of Left Atrial Appendage Closure on Clinical Outcomes In Patients with Atrial Fibrillation: A Meta-Analysis of Randomized Controlled Trials

Presenter: Mark Darkwah

March 03, 2026

Presentation THT 2026

Atrial Shunt for Heart Failure with Preserved and Mildly Reduced Ejection Fraction: Five-Year Outcomes from the REDUCE LAP-HF II Trial

Presenter: Sanjiv J. Shah

March 03, 2026

Presentation THT 2026

Medication Regimen Changes and Clinical Outcomes in the Cardiac Microcurrent (C-MIC) II Randomized Trial

Presenter: Marat Fudim

March 03, 2026

Presentation THT 2026

Artificial Intelligence Meets Real-World Heart Failure: Early Results from the HF-TRACK Trial

Presenter: Shamus Husheer

March 03, 2026

Presentation THT 2026

Incidence of HF Therapy Escalation and Time-to-Clinical Worsening in Atrial Shunt- vs. Sham-Treated Patients with HFpEF/HFmrEF During 5-Year Follow-Up: REDUCE LAP-HF II Trial

Presenter: Grant Reed

March 03, 2026

Presentation THT 2026

Optimal Mean Arterial Pressure, Time in Target Range, and Outcomes in HeartMate 3 Recipients: Pooled Individual-Patient Data from MOMENTUM-3 and ARIES-HM3 Trials

Presenter: Nelson Wang

March 03, 2026

Presentation THT 2026

Left Atrial To Coronary Sinus Shunting In Heart Failure With Mildly Reduced Or Preserved Ejection Fraction: The ALT FLOW Trial (Early Feasibility Study) 3-Year Results

Presenter: Benjamin Hibbert

March 03, 2026

Presentation THT 2026

Microaxial Flow Pump Use in Different Phenotypes of Cardiogenic Shock – a Secondary Analysis of the DanGer Shock Trial

Presenter: Elric Zweck

March 03, 2026

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for February 2026

Michael O'Riordan

March 02, 2026

Presentation THT 2026

AI in the Trenches: Lessons From Clinical Trial Optimization

Presenter: Jonathan Cunningham

March 02, 2026

Presentation THT 2026

Autologous Cell Therapy May Curb Pathological Ventricular Remodeling in Chronic Ischemic HFrEF Patients Selected for Favorable Cell Characteristics - Late Breaking Echocardiography Results from the CardiAMP HF trial

Presenter: Amish Raval

March 02, 2026

News Daily News

Surgical Mitral Valve Repair Outcomes ‘Excellent’ at 2 Years: CTSN

Yael L. Maxwell

February 26, 2026

News Conference News EAPCI 2026

AVR in Asymptomatic AS: Look to the ‘Sweet Spot’ for Timing

Caitlin E. Cox

February 25, 2026

News Daily News

Baduanjin, a Traditional Chinese Practice, Lowers BP

Todd Neale

February 20, 2026

News Conference News EAPCI 2026

AI in Cardiovascular Imaging and Interventions: Boon or Bane?

Caitlin E. Cox

February 20, 2026

News Daily News

AHA/ACC Guideline Tackles Evidence-Based Acute PE Care

L.A. McKeown

February 19, 2026

Advertisement

The Highly Dynamic Nature Of Diuretic Response In Acute Heart Failure: Insights From The FASTR Trial

Healthy Lifestyle Plus GLP-1s Yields Bigger CV Reduction Than Drugs Alone

Evaluating Electronic Health Record-Integrated Artificial Intelligence System In Combining Structured and Unstructured Data to Make Clinical Trial Eligibility Determination

Comprehensive clinical benefit of CCM in HFrEF patients – a win-ratio analysis of FIX-HF-5C randomized trial

Impact of Left Atrial Appendage Closure on Clinical Outcomes In Patients with Atrial Fibrillation: A Meta-Analysis of Randomized Controlled Trials

Atrial Shunt for Heart Failure with Preserved and Mildly Reduced Ejection Fraction: Five-Year Outcomes from the REDUCE LAP-HF II Trial

Medication Regimen Changes and Clinical Outcomes in the Cardiac Microcurrent (C-MIC) II Randomized Trial

Artificial Intelligence Meets Real-World Heart Failure: Early Results from the HF-TRACK Trial

Incidence of HF Therapy Escalation and Time-to-Clinical Worsening in Atrial Shunt- vs. Sham-Treated Patients with HFpEF/HFmrEF During 5-Year Follow-Up: REDUCE LAP-HF II Trial

Optimal Mean Arterial Pressure, Time in Target Range, and Outcomes in HeartMate 3 Recipients: Pooled Individual-Patient Data from MOMENTUM-3 and ARIES-HM3 Trials

Left Atrial To Coronary Sinus Shunting In Heart Failure With Mildly Reduced Or Preserved Ejection Fraction: The ALT FLOW Trial (Early Feasibility Study) 3-Year Results

Microaxial Flow Pump Use in Different Phenotypes of Cardiogenic Shock – a Secondary Analysis of the DanGer Shock Trial

TCTMD’s Top 10 Most Popular Stories for February 2026

AI in the Trenches: Lessons From Clinical Trial Optimization

Autologous Cell Therapy May Curb Pathological Ventricular Remodeling in Chronic Ischemic HFrEF Patients Selected for Favorable Cell Characteristics - Late Breaking Echocardiography Results from the CardiAMP HF trial

Surgical Mitral Valve Repair Outcomes ‘Excellent’ at 2 Years: CTSN

AVR in Asymptomatic AS: Look to the ‘Sweet Spot’ for Timing

Baduanjin, a Traditional Chinese Practice, Lowers BP

AI in Cardiovascular Imaging and Interventions: Boon or Bane?

AHA/ACC Guideline Tackles Evidence-Based Acute PE Care

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content